Anti-cytokine vaccine and the immunotherapy of autoimmune diseases

European Journal of Immunology

Volumn 36, Issue 11, 2006, Pages 2844-2848

  Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Autoimmune disease; Cytokine; Immunotheraphy; Interleukin 17; Vaccine

Indexed keywords

CYTOKINE ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 23; INTERLEUKIN 8; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VACCINE; CYTOKINE;

ALLERGIC ENCEPHALITIS; ARTHRITIS; AUTOIMMUNE DISEASE; CANCER; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DRUG SAFETY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION; CYTOLOGY; DRUG ANTAGONISM; IMMUNOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-17; T-LYMPHOCYTES; VACCINES;

EID: 33751231101     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636760     Document Type: Note

References (33)

1. Mosmann, T. R. and Coffman, R. L., Two types of mouse helper T-cell clone. Implications for immune regulation. Immunol. Today 1987. 8: 223-227.
2. Khoruts, A., Miller, S. D. and Jenkins, M. K., Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 1995. 155: 5011-5017.
3. Katz, J. D., Benoist, C. and Mathis, D., T helper cell subsets in insulin-dependent diabetes. Science 1995. 268: 1185-1188.
4. McKenzie, B. S., Kastelein, R. A. and Cua, D. J., Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006. 27: 17-23.
5. Liblau, R. S., Singer, S. M. and McDevitt, H. O., Th1 and Th2 CD4+ T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1995. 16: 34-38.
6. Wraith, D. C., Nicolson, K. S. and Whitley, N. T., Regulatory CD4+ T cells and the control of autoimmune disease. Curr. Opin. Immunol 2004. 16: 695-701.
7. Chu, C. Q., Wittmer, S. and Dalton, D. K., Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000. 192: 123-128.
8. Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S. et al., High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 1997. 158: 5501-5506.
9. Vermeire, K., Heremans H., Vandeputte, M., Huang, S., Billau, A. and Matthys, P., Accelerated collagen-induced arthritis in EFN-gamma receptor-deficient mice. J. Immunol. 1997. 158: 5507-5513.
10. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.
11. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
12. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179-189.
13. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
14. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 1685-1691.
15. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. and Littman, D. R., The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells. Cell 2006. 126: 1121-1133.
16. O'Garra, A. and Arai, N., The molecular basis of T helper I and T helper 2 cell differentiation. Trends Cell Biol 2000. 10: 542-550.
17. Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F. and Golstein, P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 1993. 150: 5445-5456.
18. Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y., Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice, J. Immunol. 2003. 171: 6173-6177.
19. Sonderegger, L,. Röhm, T. A., Kurrer, M. O., Iezzi, G., Zou, Y., Kastelein, R. A., Bachmann, M. F. and Kopf, M., Neutralization of IL-17 by active vaccination inhibits IL-23-mediated autoimmune myocarditis. Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636484
20. Röhn, T. A., Jennings, G. T., Hernandez, M., Great, P., Beck, M., Zou, Y., Kopf, M. and Bachmann, M. F., Vaccination against IL 17 suppresses autoimmune arthritis and encephalomyelitis Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636658
21. Uyttenhove, C. and Van Snick, J., Development of an anti-IL 17A autovaccine that prevents experimental auto-immune encephalomyelitis-Eur. J. Immunol 2006. 36: DOI: 10.1002/eji.200636662
22. Matusevicius, D., Kivisakk P., He, B., Kostulas, N., Ozenci, V., Fredrikson, S. and Link, H., Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 1999. 5: 101-104.
23. Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak K., Klimczak, E., Chwalinska-Sadowska, H. and Maslinski, W., High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 2000. 164: 2832-2838.
24. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S. et al., IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest 1999. 103: 1345-1352.
25. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T. and Fujiyama, Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003. 52: 65-70.
26. Happel, K.I., Zheng, M., Young, E., Quinton, L. J., Lockhart, E., Ramsay, A. J., Shellito, J. E. et al., Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 2003. 170: 4432-4436.
27. Kolls, J. K. and Linden, A., Interleukin-17 family members and inflammation. Immunity 2004. 21: 467-476.
28. Huang, W., Na, L., Fidel, P. L. and Schwarzenberger, P., Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 2004. 190: 624-631.
29. Bowman, E. P., Chackerian, A. A. and Cua, D. J., Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy. Curr. Opin. Infect. Dis. 2006. 19: 245-252.
30. Numasaki, M., Fukushi, J., Ono, K, Narula, S. K., Zavodny, P. J., Kudo, T., Robbins, P. D. et al., Interleukin-17 promotes angiogenesis and tumour growth. Blood 2003. 101: 2620-2627.
31. Langowski, J. L., Zhang X, Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B. et al., IL-23 promotes tumour incidence and growth. Nature 2006. 442: 461-465.
32. Benchetrit F., Ciree, A., Vives, V., Warnier, G., Gey, A., Sautes-Fridman, C., Fossiez, F. et al., Interleukin-17 inhibits tumour cell growth by means of a T-cell-dependent mechanism. Blood 2002. 99: 2114-2121.
33. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. and Fujiyama, Y., Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 2004. 110: 55-62.